P - Caution when used during pregnancy
L - Caution when used during lactation
Cefdinir (marketed by Abbott Laboratories under the brand name Omnicef) is a semi-synthetic, broad-spectrum antibiotic in the third generation of the cephalosporin class, proven effective for common bacterial infections of the ear, sinus, throat, and skin. It was approved by the U.S. Food and Drug Administration (FDA) in December 1997.
Oral
Susceptible infections
Adult: 600 mg once daily as a single or in 2 divided doses.
Child: 14 mg/kg daily. Max: 600 mg daily.
Information Not Available
Headache, dizziness, fever; nausea, vomiting, diarrhoea, abdominal pain; rash; leukopaenia, thrombocytopaenia, haemolytic anaemia.
Potentially Fatal: Anaphylaxis; renal and hepatic failure.
Monitor
Response to therapy
Monitor patient's response to therapy. Notify health care provider if infection does not appear to improve or worsens.
Sensitivity
Review results of culture and sensitivity testing as appropriate. Ensure cefdinir is discontinued and another antimicrobial agent is started if sensitivity tests indicate that the organism is resistant to cefdinir.
Side effects
Monitor patient for GI, DERM, and general body side effects, and signs of superinfection. Inform health care provider if noted and significant. Immediately report severe diarrhea, diarrhea containing blood or pus, or severe abdominal cramping.
Hypersensitivity
Reactions range from mild to life-threatening. Administer drug with caution to penicillin-sensitive patients because of possible crossreactivity.
Renal Function
Use drug with caution in patients with renal impairment. Dosage adjustment is recommended in patients with Ccr less than 30 mL/min.
Superinfection
May result in bacterial or fungal overgrowth of nonsusceptible microorganisms.
Pseudomembranous colitis
Consider possibility in patients in whom diarrhea develops.
Hemodialysis patients
A single dose of 300 mg or 7 mg/kg (max, 300 mg) may be administered at the end of each dialysis session. Subsequent doses are then administered every other day.
Overdosage
Symptoms
Seizures, nausea, vomiting, epigastric distress, diarrhea.
Penicillin-sensitive patients; superinfection; seizure; pseudomembranous colitis; pregnancy, lactation; renal or hepatic insufficiency.
Concomitant admin with antacids and Fe reduce the rate and extent of absorption. Probenecid reduces renal elimination. Antacids reduce rate and extent of absorption.
Information Not Available
Oral
Susceptible infections
Adult: 600 mg once daily as a single or in 2 divided doses.
Child: 14 mg/kg daily. Max: 600 mg daily.
May be taken with or without food
Caution when used during pregnancy.
Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is no evidence of a risk in later trimesters).
Caution when used during lactation
Safety and efficacy in children younger than 6 mo of age not established
Information Not Available
Hypersensitivity
Oral: Store at 25°C
Oral: Store at 25°C
You will hear from us only if the bid amount matches the minimum threshold and intended usage match our vision. You can resubmit another bid.